RIPK3 and metabolic dysfunction-associated steatohepatitis: In humans, Mlkl levels have been shown to be positively correlated with fibrotic markers in liver samples from patients with fibrosis/cirrhosis [75], and Ripk3 levels are correlated with increased inflammation and fibrosis in patients with MASH [52].